Chen Y. Yang
Peking Union Medical College Hospital
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Selinexor in combination with azacitidine or ruxolitinib in myelodysplastic/myeloproliferative neoplasm overlap syndromes: A multicenter prospective study.
Journal: Cancer
Published: December 26, 2025
Energy-Dependent Shifts of Medium-Scale Anisotropies in Very-High-Energy Cosmic Rays Observed by LHAASO-KM2A.
Journal: Physical review letters
Published: December 18, 2025
Transient Large-Scale Anisotropy in TeV Cosmic Rays due to an Interplanetary Coronal Mass Ejection.
Journal: Physical review letters
Published: November 17, 2025
Precise Measurement of the Cosmic Ray Helium Spectrum above 0.1 PeV.
Journal: Physical review letters
Published: November 03, 2025
Evidence of Cosmic-Ray Acceleration up to Sub-PeV Energies in the Supernova Remnant IC 443.
Journal: Physical review letters
Published: October 30, 2025
Significance of the 50% hemolytic complement in hemolysis assessment and efficacy of eculizumab in patients with paroxysmal nocturnal hemoglobinuria
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 27, 2025
First Detection of Ultrahigh Energy Emission from Gamma-Ray Binary LS I +61° 303.
Journal: Physical review letters
Published: October 24, 2025
Efficacy and safety of cyclosporine plus luspatercept versus cyclosporine in newly diagnosed non-transfusion-dependent non-severe aplastic anemia: A prospective randomized trial.
Journal: BMC medicine
Published: October 17, 2025
Adding recombinant human thrombopoietin to cyclosporine A and hetrombopag enhances the early hematologic response in transfusion-dependent non-severe aplastic anemia: a retrospective study.
Journal: Hematology (Amsterdam, Netherlands)
Published: October 03, 2025
Efficacy and safety of crovalimab versus eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: Chinese subgroup analysis of the phase 3 COMMODORE 2 study.
Journal: Annals of hematology
Published: September 10, 2025
Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study.
Journal: Annals of medicine
Published: June 19, 2025
Last Updated: 09/26/2026